MSRM Company Profile and Key Details

Average 10-day trading volume of 29.21 thousand shares is significantly above the 3-month average of 16.09 thousand, indicating heightened recent market interest.

The stock is currently mid-range between its 52-week high and low $0.01 and $0.04. With a market capitalization of about $239.27 thousand, Mushrooms Inc. is classified as a micro-cap and shows higher-than-market volatility (beta ~1.58). Key stats such as the average daily volume over the past year has been around 9.74 thousand shares, volume is running light vs its 52-week average. Headquartered in Estero, FL, Mushrooms Inc. operates in the Healthcare sector and the Biotechnology industry. Led by CEO Kimberly Carlson, the company employs approximately 6 people and listed since November 20, 2006. Mushrooms, Inc. is a biotechnology company that develops products from mushrooms and mycelium.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

Valuation shows Mushrooms Inc trading at a premium to the broader market with a P/E of -4.45.

Our AI price prediction model suggests that Mushrooms Inc stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Mushrooms Inc trades at a P/E ratio of -4.45, slightly below the S&P 500 average, with a price-to-sales ratio of 106.79 and a price-to-book ratio of -9.54 indicating negative book value, which may reflect financial stress. The P/FCF stands at 260.07, also above market averages.